Pathogenesis Corp
PGNS · Chemicals & Drugs · NASDAQ · in our data November 22, 1995 to September 21, 2000 (4.8 years)
The first trading day in our data for Pathogenesis Corp is November 22, 1995 (its first day in our records, which may be later than its listing and is not its founding). At its peak, on December 18, 1998, the market valued it at $968 million. It left the market when it was bought or merged, last trading at $38.62, -34.9% from its split-adjusted high. Holders got whatever the deal paid, which is not in our price data.
Share prices are adjusted for splits and other share changes, so the high and the last price compare like for like; the peak market value is as it was on the day. The return covers the trading days in our data only: it does not include what holders received, or lost, after the last trade (a merger payout, a bankruptcy), and it does not reach back before 1995. How these numbers are made · Report a data issue.
Could you have seen it coming? Play Dot-comAlso gone in 2000: Chemicals & Drugs
- Warner-Lambert peaked at $115.9 billion
- Pharmacia peaked at $33.3 billion
- Jones Pharma Inc peaked at $3.4 billion
- Rexall Sundown Inc peaked at $2.8 billion
- Dura Pharmaceuticals Inc peaked at $2.3 billion
- Thermolase Corp peaked at $1.5 billion
